Literature DB >> 28751161

New perspectives of physiological and pathological functions of nucleolin (NCL).

Wenyu Jia1, Zhenyu Yao1, Jiajun Zhao1, Qingbo Guan1, Ling Gao2.   

Abstract

Nucleolin (NCL) is a multifunctional protein that mainly localized in the nucleolus, it is also found in the nucleoplasm, cytoplasm and cell membrane. The three main structural domains allow the interaction of NCL with different proteins and RNA sequences. Moreover, specific post-translational modifications and its shuttling property also contribute to its multifunctionality. NCL has been demonstrated to be involved in a variety of aspects such as ribosome biogenesis, chromatin organization and stability, DNA and RNA metabolism, cytokinesis, cell proliferation, angiogenesis, apoptosis regulation, stress response and microRNA processing. NCL has been increasingly implicated in several pathological processes, especially in tumorigenesis and viral infection, which makes NCL a potential target for the development of anti-tumor and anti-viral strategies. In this review, we present an overview on the structure, localizations and various functions of NCL, and further describe how the multiple functions of NCL are correlated to its multiple cellular distributions.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cell compartments; Nucleolin; Ribosome biogenesis; Target therapy; Tumorigenesis

Mesh:

Substances:

Year:  2017        PMID: 28751161     DOI: 10.1016/j.lfs.2017.07.025

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  57 in total

1.  Post-transcriptional regulation of MMP2 mRNA by its interaction with miR-20a and Nucleolin in breast cancer cell lines.

Authors:  Sayantani Das; Soumasree De; Sumita Sengupta
Journal:  Mol Biol Rep       Date:  2021-03-31       Impact factor: 2.316

2.  ErbB-3 BINDING PROTEIN 1 Regulates Translation and Counteracts RETINOBLASTOMA RELATED to Maintain the Root Meristem.

Authors:  Ansul Lokdarshi; Csaba Papdi; Aladár Pettkó-Szandtner; Stefan Dorokhov; Ben Scheres; Zoltán Magyar; Albrecht G von Arnim; László Bögre; Beatrix M Horváth
Journal:  Plant Physiol       Date:  2019-12-09       Impact factor: 8.340

3.  Lnc00892 competes with c-Jun to block NCL transcription, reducing the stability of RhoA/RhoC mRNA and impairing bladder cancer invasion.

Authors:  Shuwei Ren; Ning Zhang; Liping Shen; Yongyong Lu; Yixin Chang; Zhenni Lin; Ning Sun; Yuanmei Zhang; Jiheng Xu; Haishan Huang; Honglei Jin
Journal:  Oncogene       Date:  2021-10-06       Impact factor: 9.867

4.  Nuclear moonlighting of the secreted growth factor heregulin drives endocrine-resistant breast cancer independently of HER2/HER3 signaling.

Authors:  Lin Yang; Travis Vander Steen; Ingrid Espinoza; Elisabet Cuyàs; Sara Verdura; Javier A Menendez; Ruth Lupu
Journal:  Am J Cancer Res       Date:  2022-05-15       Impact factor: 5.942

5.  A LINE1-Nucleolin Partnership Regulates Early Development and ESC Identity.

Authors:  Michelle Percharde; Chih-Jen Lin; Yafei Yin; Juan Guan; Gabriel A Peixoto; Aydan Bulut-Karslioglu; Steffen Biechele; Bo Huang; Xiaohua Shen; Miguel Ramalho-Santos
Journal:  Cell       Date:  2018-06-21       Impact factor: 41.582

6.  Decreased c-Myc mRNA Stability via the MicroRNA 141-3p/AUF1 Axis Is Crucial for p63α Inhibition of Cyclin D1 Gene Transcription and Bladder Cancer Cell Tumorigenicity.

Authors:  Xin Li; Zhongxian Tian; Honglei Jin; Jiheng Xu; Xiaohui Hua; Huiying Yan; Huating Liufu; Jingjing Wang; Jingxia Li; Junlan Zhu; Haishan Huang; Chuanshu Huang
Journal:  Mol Cell Biol       Date:  2018-10-15       Impact factor: 4.272

7.  Nucleolin Promotes IRES-Driven Translation of Foot-and-Mouth Disease Virus by Supporting the Assembly of Translation Initiation Complexes.

Authors:  Shichong Han; Xiaojia Wang; Junyong Guan; Jinen Wu; Yun Zhang; Pinghua Li; Zaixin Liu; Sahibzada Waheed Abdullah; Zhihui Zhang; Ye Jin; Shiqi Sun; Huichen Guo
Journal:  J Virol       Date:  2021-06-10       Impact factor: 5.103

Review 8.  Post-translational Control of RNA-Binding Proteins and Disease-Related Dysregulation.

Authors:  Alejandro Velázquez-Cruz; Blanca Baños-Jaime; Antonio Díaz-Quintana; Miguel A De la Rosa; Irene Díaz-Moreno
Journal:  Front Mol Biosci       Date:  2021-04-27

9.  The GAR/RGG motif defines a family of nuclear alarmins.

Authors:  Shan Wu; Boon Heng Dennis Teo; Seng Yin Kelly Wee; Junjie Chen; Jinhua Lu
Journal:  Cell Death Dis       Date:  2021-05-12       Impact factor: 8.469

10.  Cell surface Nucleolin represents a novel cellular target for neuroblastoma therapy.

Authors:  Chiara Brignole; Veronica Bensa; Nuno A Fonseca; Genny Del Zotto; Silvia Bruno; Ana F Cruz; Fabiana Malaguti; Barbara Carlini; Fabio Morandi; Enzo Calarco; Patrizia Perri; Vera Moura; Laura Emionite; Michele Cilli; Francesco De Leonardis; Annalisa Tondo; Loredana Amoroso; Massimo Conte; Alberto Garaventa; Angela R Sementa; Maria V Corrias; Mirco Ponzoni; Joao N Moreira; Fabio Pastorino
Journal:  J Exp Clin Cancer Res       Date:  2021-06-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.